Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II induction therapy with pemetrexed + cisplatin and concurrent pemetrexed radiotherapy in unresectable stage III NSCLC
2005-004030-40Phase 2Completed
- Sponsor
- Thoracale Oncologie Groep Antwerpen
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pemetrexed and cisplatin in non-small cell lung cancer (NSCLC), sponsored by Thoracale Oncologie Groep Antwerpen. Primary endpoint: Overall response rate. Started Dec 2005; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-004030-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004030-40.